Skip to content

DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture

DNA Methylation Biomarker in Biliary Brush Sample for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04568512
Acronym
DNA
Enrollment
67
Registered
2020-09-29
Start date
2016-01-01
Completion date
2019-12-31
Last updated
2020-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Stricture, Brush Cytology, Cholangiocarcinoma, DNA Methylation

Brief summary

DNA methylation biomarker for diagnosis of cholangiocarcinoma in patients with bile duct stricture has high sensitivity and specificity compared with cytology from the brush specimens

Detailed description

The methylation of HOXA1, NEUROG1 were used to determine cholangiocarcinoma from brushed biliary samples. However, the sensitivity and specificity of this test for cholangiocarcinoma is still required.

Interventions

DIAGNOSTIC_TESTControl

Brushed biliary samples from a known case of benign biliary stricture were sent for DNA Methylation Biomarker test and cell cytology

DIAGNOSTIC_TESTCholangiocarcinoma

Brushed biliary samples from a known case of cholangiocarcinoma were sent for DNA Methylation Biomarker test and cell cytology

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age more than 18 year old * Patients had biliary stricture from cholangiocarcinoma and benign stricture

Exclusion criteria

* Pregnancy * Patient had other malignancy

Design outcomes

Primary

MeasureTime frameDescription
The methylation of HOXA1, NEUROG1 were determined in brushed biliary samples from patients with CCAs compared to those of nonmalignant bile duct stricture2 weeksMethylation index of biliary brush samples were analyzed.

Secondary

MeasureTime frameDescription
Sensitivity, specificity of DNA methylation for diagnosis of cholangiocarcinoma2 weeksDiagnostic accuracy of methylation index for diagnosis of cholangiocarcinoma was analyzed.
To compared sensitivity, specificity of DNA methylation with routine cytology of biliary brushed samples2 weeksDiagnostic accuracy of methylation index was compared to routine brush cytology.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026